🌐 sacituzumab tirumotecan
Sacituzumab tirumotecan is a targeted antibody–drug conjugate monitored globally for developments in clinical trials, regulatory approvals, and cancer treatment.
3
Signals
6
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Koalas are cute, furry, iconic – and dying of chlamydia. But how well does the approved vaccine work? | expired | Health | involved | 100% | |
| Intermittent fasting plus exercise boosts fat loss and fitness in 12-week obesity trial | expired | Health | involved | 100% | |
| First 90 days after starting antipsychotics are critical for monitoring diabetes risk, study finds | expired | Health | involved | 100% |